好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | C217 - Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing

Thursday 04/27/17
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Michael E. Shy, MD, FAAN
Participants should be able to determine when to consider ordering genetic testing for patients with neuropathy; determine when testing is positive or negative and have an approach of what to do when results are inconclusive; and understand the different forms of next generation sequencing and the strengths and weaknesses of these forms.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider
Case-based, Didactic, Interactive, Audience Participation
Event Timeline
03:30 PM - 04:15 PM Speaker Interpreting Genetic Testing Results in Patients with Inherited Neuropathies
Shawna Feely
04:15 PM - 05:00 PM Speaker Advances and Limits of Next Generation Sequencing Beyond Clinical Testing
Stephan Zuchner, MD, FAAN
05:00 PM - 05:30 PM Q&A Questions and Answers/Case Presentations
Shawna Feely, Stephan Zuchner, MD, FAAN
Faculty Disclosures
Michael E. Shy, MD, FAAN Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.
Stephan Zuchner, MD, FAAN Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Shawna Feely Shawna Feely has nothing to disclose.